LENZ Therapeutics, Inc. (LENZ)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
33
$87.50M held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| FMR LLC | Aug 13, 2026 | $20.21M |
| BlackRock, Inc. | Aug 7, 2026 | $13.02M |
| FRANKLIN RESOURCES INC | May 13, 2026 | $10.07M |
| MILLENNIUM MANAGEMENT LLC | Aug 14, 2026 | $8.57M |
| Vanguard Capital Management | Aug 13, 2026 | $6.24M |
LENZ's filings are public. The insight is one click away.
Scrutar's AI reads every LENZ filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze LENZ filingsNo credit cardAI reports included on the free plan
Never miss a LENZ filing.
Get an email when LENZ files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 30, 2026Source: SEC EDGAR.